Tempothera
1 known investors
Tempo Thera develops tissue engineering products using MAP technology that combine immunomodulation and material science for soft tissue reconstruction in surgical settings. The company builds functional tissue and organs to treat patients with dermal and abdominal wall indications, with expanding pipeline into drug delivery, cell engraftment, and vaccine technologies.
BiotechHealthtechMedical Devices